KCTD11 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
DAPT is a γ-secretase inhibitor, impacting Notch signaling. By inhibiting Notch signaling, DAPT could lead to compensatory mechanisms that might indirectly activate KCTD11, as KCTD11 is implicated in processes inversely related to Notch pathway activation. | ||||||
RO-4929097 | 847925-91-1 | sc-364602 sc-364602A | 10 mg 50 mg | $430.00 $1389.00 | 1 | |
RO4929097 is a γ-secretase inhibitor that affects Notch signaling. This inhibition might lead to indirect activation of KCTD11, considering its potential role in pathways counteracting Notch signaling effects. | ||||||
MK-0752 | 471905-41-6 | sc-364534 sc-364534A | 10 mg 50 mg | $592.00 $1550.00 | ||
MK-0752, a γ-secretase inhibitor, can modulate Notch signaling. Its influence on Notch signaling could lead to an indirect activation of KCTD11 through altered cellular signaling mechanisms. | ||||||
Dibenzazepine (Deshydroxy LY 411575) | 209984-56-5 | sc-207554 sc-207554A | 2 mg 5 mg | $100.00 $260.00 | 4 | |
DBZ is a potent γ-secretase inhibitor. By inhibiting Notch signaling, DBZ might indirectly activate KCTD11, particularly in cellular contexts where KCTD11 is involved in Notch-opposing pathways. | ||||||
PF-3084014 | 1290543-63-3 | sc-507501 | 5 mg | $130.00 | ||
PF-03084014, another γ-secretase inhibitor, can affect Notch signaling. This could lead to an indirect activation of KCTD11, especially in systems where KCTD11 functions are inversely related to Notch pathway activation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin affects multiple signaling pathways and could modulate Notch signaling indirectly. This modulation might activate KCTD11, considering KCTD11's potential role in Notch-regulated processes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol impacts various signaling pathways, including sirtuins and AMPK, which can intersect with Notch signaling. This intersection might indirectly lead to KCTD11 activation due to its role in counterbalancing Notch activity. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Sulforaphane, a Nrf2 activator, can influence various cellular pathways, potentially affecting Notch signaling. This influence might indirectly activate KCTD11 by altering the cellular signaling milieu. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin affects multiple signaling pathways and could indirectly modulate Notch signaling. This modulation might lead to KCTD11 activation, considering its involvement in pathways that are inversely regulated by Notch. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, can influence several signaling pathways. Its effects might lead to indirect activation of KCTD11, especially in contexts where KCTD11 function is related to pathways influenced by tyrosine kinase activity. | ||||||